Small Bone Innovations makes Orthofix veteran Michael Simpson CEO
This article was originally published in Clinica
Executive Summary
Privately-held orthopaedics firm Small Bone Innovations (SBi) has appointed a new president and CEO, former Orthofix executive Michael P Simpson. He succeeds Anthony Viscogliosi, SBi's CEO and chairman since 2005 and a founder of the company; Mr Viscogliosi will now become executive chairman. Mr Simpson worked for Orthofix, a unit of Orthofix International, for nine years, most recently as division president, where he was responsible for global development and distribution, with full P&L responsibility. Mr Simpson is no relation to Michael J Simpson, who was SBi's president and chief operating officer from 2005-2008. Morrisville, Pennsylvania-based SBi has seen a compound annual growth rate of 27% during 2006-2011. The firm is targeting the $3.3bn small bone and joint market with products including its STAR total ankle replacement system.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.